Table 1.
Characteristics | Patients (n), N=455 | Study groups
|
p-value between groups | |
---|---|---|---|---|
Oscillococcinum (N=246) | Control (N=209) | |||
Gender | 0.0532 | |||
Male | 219 | 115 | 104 | |
Female | 236 | 131 | 105 | |
Age classes | 0.0193 | |||
Adults | 286 | 139 | 147 | |
Pediatric | 169 | 107 | 62 | |
Diagnosis | <0.001 | |||
RRI | 107 | 88 | 19 | |
Adults | 0 | 0 | 0 | |
Pediatric | 107 | 88 | 19 | |
RTI | 114 | 43 | 71 | 0.0015 |
Adults | 89 | 41 | 48 | |
Pediatric | 25 | 2 | 23 | |
Allergic respiratory diseases | 65 | 24 | 41 | 0.0526 |
Adults | 51 | 22 | 29 | |
Pediatric | 14 | 2 | 12 | |
Asthma | 102 | 55 | 47 | 0.2157 |
Adults | 79 | 40 | 39 | |
Pediatric | 23 | 15 | 8 | |
COPD | 67 | 36 | 31 | 0.3731 |
Adults | 67 | 36 | 31 | |
Pediatric | 0 | 0 | 0 |
Notes: Oscillococcinum® manufactured by Boiron, Messimy, France. Adults: >12 years; pediatric: ≤12 years.
Abbreviations: RRI, recurrent respiratory infection; RTI, respiratory tract infection.